课题基金 / 基金详情

SAFETY AND IMMUNOGENICITY OF CANARYPOX CMV (VCP260) IN HEALTHY ADULTS

SAFETY AND IMMUNOGENICITY OF CANARYPOX CMV (VCP260) IN HEALTHY ADULTS
金丝雀痘 CMV (VCP260) 对健康成年人的安全性和免疫原性
批准号:
6219840
负责人:
Stuart E Starr
金额:
$0.06万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

Stuart E Starr的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Thirty-eight (38) patients were screened for eligibility. Screening was completed on March 31, 1998. Twenty-seven (27) patients have been enrolled and have received all 4 doses of vaccine. Fifteen(15) patients have completed the study. Five (5) patients will have their final visit in April, 1999. Four (4) patients will have their final visit in June, 1999. One (1) patient dropped out after dose #1. One (1) patient was dropped from the study due to a severe local reaction after dose #2. One (1) patient was dropped from the study for not meeting entrance criteria. There have been no serious adverse events related to study vaccine. Preliminary results indicate that the vaccine were immunogenic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACTG377--ANTIRETROVIRAL REGIMENS W/ COMBOS OF PROTEASE INHIBITORS
  • 批准号:
    6595455
  • 项目类别:
  • 资助金额:
    $18.67万
  • 财政年份:
    2002
  • 负责人:
    Stuart E Starr
  • 依托单位:
ACTG377--ANTIRETROVIRAL REGIMENS W/ COMBOS OF PROTEASE INHIBITORS
  • 批准号:
    6306322
  • 项目类别:
  • 资助金额:
    $0.06万
  • 财政年份:
    1999
  • 负责人:
    Stuart E Starr
  • 依托单位:
ACTG185--USE OF HIVIG FOR PREVENTION OF MATERNAL/FETAL TRANSMISSION OF HIV
  • 批准号:
    6116874
  • 项目类别:
  • 资助金额:
    $2.47万
  • 财政年份:
    1998
  • 负责人:
    Stuart E Starr
  • 依托单位:
ACTG 265--LIVE ATTENTUATED VARICELLA VACCINE IN HIV INFECTION CHILDREN
  • 批准号:
    6116899
  • 项目类别:
  • 资助金额:
    $2.47万
  • 财政年份:
    1998
  • 负责人:
    Stuart E Starr
  • 依托单位: